CA Hull gets 31.2% in Sequent via Viyash merger; no open offer needed
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Pursuant to NCLT-approved composite scheme (order Nov 18, 2025), Sequent Scientific allotted 13,61,60,231 shares (31.2% of capital) to CA Hull Investments at 56:100 exchange ratio. CA Harbor (existing promoter) stake fell from 52.33% to 30.20%. Combined promoter group now holds 61.4%. Transaction exempt from open offer under Regulation 10(1)(d)(ii) of SEBI Takeover Regulations.
Viyash merged into Sequent at 56:100 ratio; promoter group now 61.4% combined; no open offer triggered; shareholding reshuffled.